ht-6184
Small moleculeexperimental
Clinical trial activity
4 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Jun 15, 2022 (NCT05447546)
Timeline
Indications
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07172867 | Phase 2 | Sep 30, 2025 | Halia Therapeutics, Inc. |
| NCT06241742 | Phase 2 | Feb 12, 2024 | Halia Therapeutics, Inc. |
| NCT07052006 | Phase 2 | Dec 9, 2023 | Halia Therapeutics, Inc. |
| NCT05447546 | Phase 1 | Jun 15, 2022 | Halia Therapeutics, Inc., TKL Research |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Halia Therapeutics, Inc. | For profit | 4 | 4 | 2 | 2022 |
| TKL Research | For profit | 1 | 0 | 1 | 2022 |
2 organizations
Page 1 / 1